Momenta Pharmaceuticals, Inc. (MNTA)

[flatlander_60048]

MNTA has shown that They will rigorously defend their IP. However, TEVA has shown on several occasions that they are not afraid of launching at risk, burying the opponent in legal motions negotiating a way out.

The 2013 patent litigation is only a little more than a year off. I have not completely written off the idea that TEVA may find a way to get their Lupenox to market, however I think it is less likely that it will clear the bar as a biogeneric.

FL